Downloadable! This paper proposes a method to calculate undistributed profits, thus saving rates of non-financial firms using only the information given in their balance sheets. This allows us to analyze the saving behavior of non-financial firms even in the absence of their statement of cash flows, which contains dividend payments data. The balance sheets of non-financial firms are provided by TurkStat only for 2013 and 2014, so this paper is confined to the cross sectional analysis of the saving behavior of non-financial firms in Turkey. We find that the saving rate increases as past net profit margin increases for firms with profits in the preceding year. For the firms which declare loss in the preceding year, saving rate increases as the past value of net profit margin decreases. Our findings for the rest of the firm-level determinants are consistent with the previous studies: Firm size plays a role on corporate savings; leverage ratio has a negative impact on the saving rate; and the positive
A seriously flawed and inflammatory attack on conflict of interest policies and regulations appeared recently in a most unexpected location: the venerable and trusted New England Journal of Medicine (NEJM). In a series of rambling articles, one of the journals national correspondents, Lisa Rosenbaum, supported by the editor in chief, Jeffrey Drazen, tried to rationalise financial conflicts of interest in the medical profession.1 2 3 4 As former senior editors of the NEJM, we find it sad that the medical journal that first called attention to the problem of financial conflicts of interest among physicians would now backtrack so dramatically and indulge in personal attacks on those who disagree.. Physicians and the public rely on journals as unbiased and independent sources of information and to provide leadership to improve trust in medicine and the medical literature. Yet financial conflicts of interest have repeatedly eroded the credibility of both the medical profession and journals.5 6 As ...
In the event that an undisclosed financial interest on the part of an author is brought to the editors attention (usually during the review process), the editor should remind the author of the journals policy and ask the author if he or she has anything to disclose. The authors reply may affect the editorial decision on whether to publish the manuscript. If an editor receives information (usually from a reader) alleging that an author has not disclosed a financial interest in the subject of an article that has been published, the editor should contact the author and ask for an
In the event that an undisclosed financial interest on the part of an author is brought to the editors attention (usually during the review process), the editor should remind the author of the journals policy and ask the author if he or she has anything to disclose. The authors reply may affect the editorial decision on whether to publish the manuscript. If an editor receives information (usually from a reader) alleging that an author has not disclosed a financial interest in the subject of an article that has been published, the editor should contact the author and ask for an
For years, such consulting payments have raised concerns about the impact of money on a doctors decision about which drugs to prescribe or how to interpret research findings. Money can also shift a physicians sense of loyalty, said George Loewenstein, a professor at Carnegie Mellon University who has studied medical conflict-of-interest policies. "If someone has been paying you or employing you, it is very difficult to blow the whistle," said Professor Loewenstein, who teaches economics and psychology. "It offends our sense of loyalty ...
Grant Support: The authors are funded by their academic institutions.. Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M15-1277.. Editors Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that she has no financial relationships or interests to disclose. Darren B. Taichman, MD, PhD, Executive Deputy Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports ...
Acknowledgment: The authors thank the patient for sharing her story.. Grant Support: Beyond the Guidelines receives no external support.. Disclosures: Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?ms Num=M15-2885.. Editors Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that she has no financial relationships or interests to disclose. Darren B. Taichman, MD, PhD, Executive Deputy Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships ...
Susan Darlow, PhD; Karin Hoffmann, RN, CCM. The ACCME/ANCC/ACPE defines "conflict of interest" as when an individual has an opportunity to affect CE content about products or services of a commercial interest with which he/she has a financial relationship.. ACCME, ACPE, and ANCC focuses on financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content of the CE activity. ACCME, ACPE, and ANCC have not set a minimal dollar amount for relationships to be significant. Inherent in any amount is the incentive to maintain or increase the value of the relationship. The ACCME, ACPE, and ANCC defines "relevant financial relationships" as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.. All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation to the tasks ...
The new Harvard University Policy on Individual Financial Conflicts of Interest for Persons Holding Faculty and Teaching Appointments (University Conflict of Interest Policy) is built upon 12 principles that establish a framework to guide the Schools in developing their implementation plans.
On September 17, 1999, 18 year-old Jesse Gelsinger became the first subject in a gene transfer clinical trial to die from a reaction to a recombinant viral vector. Jesse suffered from a deficiency of ornithine-transcarbamylase (OTC), a necessary enzyme, and enrolled in a Phase I dose-escalation trial at the University of Pennsylvania. The clinical trial involved the injection of an adenoviral vector containing the gene. Jesse died after receiving the injection.. Subsequent investigations found that the Principal Investigator was an inventor for the technology used in the trial and held equity in the start-up company to which the technology was licensed. This case brought significant attention to the issue of financial conflicts of interest in research. Additional information about financial conflict of interest can be found on the NIH Conflict of Interest (COI) Page. The HHS regulations governing conflicts of interest, "Responsibility of Applicants for Promoting Objectivity in Research for Which ...
In accordance with the disclosure policies of the Accreditation Council for Continuing Medical Education (ACCME) and FDA guidelines, it is a policy at the ASN for individuals who are in a position to control the content of an educational activity to disclose to the activity participants: 1) the existence of all relevant financial relationships with any commercial interests or other relationships with the manufacturers of any commercial products/devices, or providers of commercial services, that relate to the content of their presentation/materials, or the commercial contributors of this activity, that could be perceived as a real or apparent conflict of interest; for this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner and 2) the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device not yet approved ...
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.. The faculty reported the following:. Dr. R. Jain: Advisory Board: Addrenex, Alkermes, Avanir, Forum, Janssen, Lilly, Lundbeck, Merck, Neos Therapeutics, Neurocrine Biosciences, Otsuka, Pamlab, Pfizer, Shionogi, Shire, Sunovion, Supernus, Takeda, Teva; Consultant: Addrenex, ...
Footnotes. This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.. Conflict of interest: Dr. EYRIES reports personal fees from Roche Diagnostics France, during the conduct of the study.. Conflict of interest: Dr. NADAUD has nothing to disclose.. Conflict of interest: Dr. Girerd has nothing to disclose.. Conflict of interest: Dr. LEVY has nothing to disclose.. Conflict of interest: Dr. Bourdin reports grants, personal fees and non-financial support from GSK, grants, personal fees and non-financial support from Astra Zeneca, personal fees and non-financial support from Novartis, grants from MSD, grants and personal fees from Actelion, grants, ...
UC addresses the various aspects of financial conflicts of interests in research through a number of principles, guidelines and policies intended to promote the conduct of research without bias and with the highest scientific and ethical standards.. The University and the Fair Political Practices Commission maintain a list of sponsors that are exempt from the Universitys non-governmental entity financial disclosure requirement.. Contact: Timothy Miller at [email protected] or (510) 987-0647.. ...
The typical conflict of interest arguments that are seen in medicine have to do with financial conflict of interest. If the current reporting database is to be believed they may be considerable. A commentary from Nature earlier this month (5) speaks to the non-financial side of conflicts of interest. The primary focus is on reproducibility as a marker of quality research. They cite the facts that 2/3 of members of the American Society for Cell Biology were unable to reproduce published results and that pharmaceutical researchers were able to reproduce the results from 1/4 or fewer high profile papers. They cite this as the burden of irreproducible research. They touch on what scientific journals have done to counter some of these biases, basically checklists of good design and more statisticians on staff. That may be the case for Science and Nature but what about the raft of online open access journals who not only have a less rigorous review process but in some cases require the authors to ...
Canadian universities are allowing faculty to engage in conflict-of-interest relationships, bring in external lecturers, accept gifts, research funding, and scholarships for their students," she said. "Each of these ties to drug companies can contribute to biased understandings and the dissemination of incorrect information on drugs… Furthermore, having affiliations with drug companies is considered a prestigious and acceptable practice by medical students, who are not taught to decode what these relationships mean." ...
In my opinion, a conflict of interest does not disappear overnight. In the present case, I believe that the existence of a 13 year period during which the researcher held a Big Pharma endowed chair position is absolutely relevant today, even though the researcher has resigned that position. I believe that readers deserve to be informed about that 13-year financial relationship between the researcher and the pharmaceutical industry and that this relationship is relevant to the evaluation of potential bias in the conduct and reporting of the research, even though the relationship ceased to exist in early 2010. Thus, I believe that the conflict should continue to be reported and that the investigator has an obligation to inform journal readers of the past financial relationship ...
The researchers found that, while 83.3% of "clean" systematic reviews (with no conflict of interest) concluded that consuming soft drinks was a potential risk for weight gain, 83% of the reviews in which the authors admitted links with the industry gave the result that the scientific evidence for associating such consumption with weight increase was insufficient. "These findings, underlined Ms. -Rastrollo, increase concern about the exactitude of the results from research financed by the food and drinks industry, although it is true that this research cannot evaluate which available interpretation is correct. In any case, this concern is supported by random and controlled trials amongst both children and adults, and in which a risk association between the consumption of soft drinks and weight gain was observed". The researchers from the University of Navarra point out that "for authors stating they do not have a conflict of interest, systematic reviews financed by the drinks or sugar industry ...
More than a year ago, Ned Feder, former National Institutes of Health researcher and now staff scientist at the linkurl:Project on Government Oversight,;http://www.pogo.org/index.shtml wrote in a linkurl:letter;http://www.the-scientist.com/article/display/43576/ appearing in the __The Scientist__ that NIH-funded scientists have been filing financial disclosure statements within their own institutions. However, their disclosure statements are kept secret, within each institution.
Industry provides essential funding but can present researchers with a conflict of interest, argues David Weatherall. For vice-chancellors of impoverished universities, the growing links between academia and industry and the resulting sources of income must be welcome. The situation is equally attractive to academics who see it as a way of augmenting their miserable pay. But the increasing pressures on universities to move in this direction from government funding bodies are presenting problems that could have serious implications. Nowhere are these stresses and strains more evident than in biomedical research. Recently, the New England Journal of Medicine, which justly prides itself on its particularly tough conflict-of-interest guidelines, had to apologise publicly for falling standards over the past few years. An internal inquiry disclosed that nearly half the 40 articles on drug therapy published since 1997 were written by authors with serious conflicts of interest based on their ...
The Stark Law, you should know, generally prohibits physicians from referring Medicare patients for certain designated health services to entities with which the physician (or immediate family members) has a financial relationship (i.e., self-referring), and it prohibits the entity from billing Medicare for services provided pursuant to such prohibited referral.. The "financial relationship" that a physician might have with an entity can come in many forms: through his/her ownership of an interest in the entity, through employment (i.e., the "entity" can be the doctors own group practice) or independent contract with the entity, or some other contractual relationship with the entity. A typical example might be a physicians part ownership of a laboratory facility to which he refers a patient. Or, instead, perhaps the physician is the medical director of the lab to which he refers a patient. Or, the physician leases space, as landlord, to the lab.. The designated health services covered by Stark ...
USOC President LeRoy Walker has dropped the organizations conflict-of-interest issue regarding the selection of a new President. The matter will not be on the Executive Boards agenda this weeken
However, many initiatives have been taken in the recent years like the new Strategic purchase model with private industry involvement,Defence procurement focus on Indigenous design ,development & manufacturing "IDDM",Make in India & Skill India mission .All these need to be implemented effectively.. Similarly recent reports of CAG on Akaash missiles and defence procurement needs to be taken seriously.. India needs to emulate the French model of integrated procurement and acquisition structure.. ...
I have shown you previously that there are any number of ways to set up studies to get the results you are looking for. More specifically, many researchers use a technique commonly known as "Data Mining". When researchers "mine" data, it means that they do their study, and then look at the data to see if there is any conceivable way that it can be twisted to get to the sought after end point. Oh; I see. You are one of those people who still believe that scientific research is "independent", "unbiased", and "untainted" by financial conflicts of interest. Trust me. With our government so deeply entwined with so-called "EVIDENCE-BASED MEDICINE" (HERE is one such example), and drug companies always looking for new ways to cash in, it is difficult to trust anyone anymore. Science is bought and paid for by the highest bidder. Mostly it is whatever he who has the most cash says it is. Dont believe me? Check out the link on EBM above ...
Disclosure Statement of Financial Interest I, Carlo Briguori DO NOT have a financial interest/arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation. This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and well adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in
This is the first systematic examination of financial conflicts of interest in medicine. Marc Rodwin examines the evolution of those medical practices and institutions that left the profession open to conflicts of interest and makes clear suggestions for reform.
XVIIIe Colloque panquébécois des étudiants et étudiantes de l Institut des sciences mathématiques 15 au 17 mai Mot du comité d organisation Chers participants, C est avec grand plaisir que nous
Biomarkers in Colorectal Cancer Management: KRAS Mutations and EGFR Inhibitors. Mace L. Rothenberg, M.D. Professor of Medicine Ingram Professor of Cancer Research. Conflict of Interest Disclosure. Consultant or Advisory Role. Stock Ownership. Biomarkers in CRC Management. Slideshow 5124493 by caraf
Continuing his efforts to keep a spotlight on cozy financial relationships between industry players and physicians, Sen. Chuck Grassley (R-IA) is asking tough questions about the relationship between
Shop With the 20th century fast approaching and the landscape on conflict rapidly changing the British government felt the need to update their standard issue L1A1 battle rifle to something more suited to the changing face of modern war. Born from this effort came the L85A1 assault rifle, a gas operated ... , Airsoft Guns, Airsoft Electric Rifles, JG / GB / Jing Gong
Shop With the 20th century fast approaching and the landscape on conflict rapidly changing the British government felt the need to update their standard issue L1A1 battle rifle to something more suited to the changing face of modern war. Born from this effort came the L85A1 assault rifle, a gas operated ... , Airsoft Guns, Airsoft Electric Rifles, JG / GB / Jing Gong
The five-page complaint, which was obtained by The Hill, accuses Issa of using his position as chairman of the House Oversight and Government Reform Committee to add to his multimillion-dollar fortune. An Issa spokesman on Monday said the allegations have absolutely no merit and are part of a smear campaign spearheaded by the White House.. The complaint alleges that Issa pressured the Securities and Exchange Commission (SEC) to halt an investigation of Goldman Sachs shortly after he bought a huge stake in one of Goldman s high-yield mutual funds.. It also claims Issa used his authority to improperly defend Merrill Lynch, a firm with which he has a significant financial interest, the document states ...
Some physicians have a financial stake in the sales of medical devices they implant into patients. Few disclose their financial interest.
For generations we have entrusted our medical care to doctors. The medical system, however, has been hijacked by the corporate financial interests of Big Pharma and the major multinational surgical supply companies. We can no longer trust that the system is working in our best interests.. While the system excels at treating trauma and acute care, its approaches to the chronic conditions of womens health are appallingly ineffective and often harmful. As women, we must now be far more educated about our own body in order to safely direct our own care, be it in or outside the traditional medical system.. Christine Kent ...
I certify that I have no affiliations with or involvement in any organization or entity with a financial interest in the subject matter of my feedback ...
I certify that I have no affiliations with or involvement in any organization or entity with a financial interest in the subject matter of my feedback ...
5: 1101-1112 Crossref Optimal generic download an elementary proof non-financial department of MG-63 subtasks in regenerative science scaffoldWen-Ta Su, Yun-Ting Wang, Chih-Ming ChouJournal of the Taiwan Institute of Chemical Engineers. calcium Editorial for food delivery engineeringHuifeng Wang, Jing Li, Hailin Yang, Chao Liu, Jianming RuanMaterials Science and Engineering: C. 40: 71-75 detection automata of successfully prominent implanted ideal challenges with micro-channelsZhi-xiang Cui, Hai-bin Zhao, Yi-yan Peng, Yottha Srithep, Lih-Sheng Turng, Chang-yu ShenChinese Journal of Polymer Science. Rozina Ashraf, Ayesha Kausar, Muhammad SiddiqIranian Polymer Journal. 7: 531-545 Crossref Surface download an elementary proof of the cayley hamilton theorem of syndrome Reports promoted via domestic tax working for Crossref value engineeringChih-Hao Chen, Ming-Yih Lee, Victor Bong-Hang Shyu, Yi-Chieh Chen, Chien-Tzung Chen, Jyh-Ping ChenMaterials Science and Engineering: C. 40: 389-397 Crossref ...
Spire Wellesley Hospital - CMA compliance. Specific information about our relationship with consultants, including key charges made by Spire and any financial interests in Spire held by referring clinicians are set out below.
I just came across this product on Prohealth. I have no financial interest in Prohealth....just wondering if anyone has tried it or heard of it, and...
Global IT executive Jitender Arora and Dwayne Melancon, Tripwires CTO, will demonstrate the pitfalls and offer tips and tricks for communicating security initiatives with executives and non-financial stakeholders. In this webcast, you will learn how to: ...
According to the projections of the Queensland Treasury, the non-financial public sector (NFPS) debt will grow to $81 billion by 2020-21 (Table D1, 2017-18 Budget Paper 2). Is this a reason to be…
Monthly amount of private non-financial corporations sterling and all foreign currency funds raised from UK MFIs and capital markets (in sterling millions) seasonally adjusted ...
Monthly changes of monetary financial institutions sterling and all foreign currency loans to all non-financial businesse (in sterling millions) seasonally adjusted ...
In compliance with UEMS/EACCME guidelines, the authors and experts involved in the elaboration of the e-learning activity confirm that they have disclosed any potential conflicts of interest or support that might cause a bias in their presentation.. Professor Jacques Marescaux, WebSurg Editor in Chief, accepts that WebSurg is responsible for ensuring that all potential conflicts of interest relevant to the e-learning activity are declared to the learners prior to engaging in it. ...
By Jaebeom Kim; Abstract: The goal of this paper is to examine the hypothesis of real interest rate parity by contrasting real interest rates
have used relation between interest rate forex Analysis - relation between interest rate forex, forex bliss for free, download forex megadroid, www forex fio
Опросы на сайте e-opros.ru. Ваше мнение важно для нас. Получайте за него деньги ...
Для развития любого вида творчества нужна критика.С помощью критики можно указывать на недостатки,что в свою очередь поможет прогрессиров ...
ACP Internist and American College of Physicians Internal medicine physicians are specialists who apply scientific knowledge and clinical expertise to the diagnosis, treatment, and compassionate care of adults across the spectrum from health to complex illness. ACP Internist provides news and information for internists about the practice of medicine and reports on the policies, products and activities of ACP. All published material, which is covered by copyright, represents the views of the contributor and does not reflect the opinion of the American College of Physicians or any other institution unless clearly stated. ...
Most important medical journals have conflict of interest disclosure policies, but barely half require individual disclosure from every author, and the details on what to disclose vary considerably, r
A new study suggests the revised mental health bible, scheduled for publication in May 2013, is ripe with financial conflicts of interest.
A. Statement of Purpose INSIDER TRADING POLICY (To be read in conjunction with the Disclosure Policy) This and Insider Trading Policy (the Policy ) exists to advise all directors, officers, employees and
To date, this blog has not accepted payment in the form of advertisements, sponsored topics or any other exchange of goods or money. Free product and services have not been accepted. Should this change, the Disclosure Policy will be updated and the title changed to indicate the date. Therefore, the appearance or mention of any product or service can be assumed to be a result of my own personal opinion which remains uninfluenced by the potential for financial gain ...
... - a blog that containing of health articles, also focus on health issues, medicare and all disease
As a security company, keeping our customers safe is Sophoss primary concern. Sophos uses a Secure Development Lifecycle process to integrate security into its products from design, through development and release. However, sometimes vulnerabilities escape detection, or new exploits are released after the product is already on the market.. At Sophos we investigate all received vulnerability reports and implement the best course of action in order to protect our customers.. If you are a security researcher and have discovered a security vulnerability in our products, we appreciate your help in disclosing it to us in a responsible manner.. If you identify a verified vulnerability in compliance with Sophoss Responsible Disclosure Policy, Sophos commits to:. ...
The New York Eye and Ear Infirmary of Mount Sinai requires that each teacher/contributor or individual in a position to control the content of a CME activity accredited by the New York Eye and Ear Infirmary disclose the existence of any relevant financial interests or other relationships (e.g. paid speaker, employee, paid consultant on a board and/or committee for a commercial company) that would potentially affect the objectivity of activity content. Teachers/Contributors are also asked to make a disclosure that a product is still investigational when an unlabeled use of a commercial product or an investigational use, not yet approved for any purpose, is discussed during an educational activity. The disclosed information in no way presumes to assess the contributors qualifications or suitability. The intention is to provide full disclosure of any potential conflict of interest, real or apparent, which is related to a specific educational activity. Individuals who neglect to provide information ...
Under the PID Act, every Australian Government agency must appoint authorised officers to handle public interest disclosures. Disclosures can also be made to a supervisor or manager, who must pass it to an authorised officer.. AIHW authorised officers are:. Mr Andrew ...
Assisted reproductive technology is a highly profitable global industry, with fertility clinics increasingly being regarded as an attractive investment option.
The fake Willie Soon controversy comes back to bite Harvard in the rear.. Heres the original story that broke on JunkScience.com this morning.. Below is Lord Moncktons letter to Harvard (Click image to enlarge). Click here for PDF version.. ...
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own ...
As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines "relevant financial relationships" as financial relationships in any amount occurring within the past 12 months that creates a COI.. Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.. ...
A. All Academy Leaders and persons in a position to influence the content of Academy-sponsored CME must submit a Disclosure Form of all financial relationships in any amount and uncompensated interactions with Companies within the previous 12 months prior to their participation in the activity. In the context of this Conflict of Interest policy, "CME" encompasses the Academys full spectrum of educational activities, including those qualifying for CME credit, as well as the Academys non-credit-bearing educational initiatives, programming and products, including but not limited to ONE Network non-accredited content, practice management resources, quality of care research and publications, and Journal article authorship, selection and review.. B. Members of the Board of Trustees and members of the Committee of Secretaries will be asked to disclose additional information on the Academy Leader Disclosure Form indicating whether their disclosed direct financial relationships with Companies are under ...
24 June 2017 - Medical Representative Jobs in U.A. Biotech Pvt. Ltd. - Jabalpur. Having the Prior experience of minimum 6 Months.Qualification :- Graduate in any discipline.Experience :-
It influences how physicians make decisions and how guideline panels come up with their guidelines," said Brett D. Thombs, of McGill University and the Jewish General Hospital in Montreal, whose findings are published in the Journal of the American Medical Association (JAMA ...
Note: At a White House press conference Monday, President Donald Trump announced that he may soon roll back federal guidelines on social distancing that are intended to stem the spread of the coronavirus epidemic. The Washington Post has reported that Trumps
The Guardian The government yesterday announced sweeping changes to the medicines watchdog body after years of criticism and pressure, banning those who sit on its central licensing committee from having any personal or financial interests in pharmaceutical companies. Lord Warner, the health minister, said those who sat on the regulatory body would in future have three months to sell their shares and end their potentially lucrative consultancy agreements with drug companies. As the Guardian revealed last month, many of the doctors and scientists who sit on the present Committee on the Safety of Medicines (CSM), granting drug companies licences to sell medicines, also work as paid consultants to the industry. In 2001, 17 out of 36 members declared personal financial interests in drug companies, while more had indirect interests. When drugs in which they have an interest are discussed, members have to leave the room. Lord Warner yesterday went further than expected with a root and branch excision ...
Note: drug companies have a vested interest in promoting drug, rather than dietary, approaches to LDL-lowering.. Comment: Conflicts of interest do not necessarily mean that the results of the study were manipulated or wrong. They do mean that the methods and results require more than the usual level of scrutiny. Sponsored studies almost invariably produce results consistent with the sponsors economic or marketing interests.. Its likely that some industry-sponsored studies produce conclusions contrary to the sponsors interest. If you know of any, please send.. ...
1. Many of the reviews contain lots of factual information that is easily verifiable. We always try to provide an honest and accurate assessment.. 2. The review includes a section that is a subjective summary. This is based on the personal experience of the reviewer.. 3. Attempts are made to establish the general consensus in relation to specific products by reading reviews of those products on other sites, along with user testimonials and we attempt to portray this overall perception in our reviews.. 4. We always provide links to the manufacturers website to provide additional information that is not available in our reviews. Some of this information can include customer testimonials, more specific product details, sales information, free newsletters and even samples.. These are good rules of practice. It is important for you as a consumer to understand the relationship between a person reviewing the product and the manufacturer. ...
As we want all the information on Hypertension Solutions to be as accurate as possible we pass the responsibility of researching and writing the articles on Hypertension Solutions to real Doctors and the name of the Doctor that has researched and written the article will be at the bottom of each article.. ...
Each speaker is required to disclose any relevant financial relationships at least six weeks prior to the scheduled presentation date. Speakers refusing to disclose relevant financial relationships will be disqualified from any involvement in the activity. Disclosures are published in the activity materials and are also presented in a PowerPoint slide prior to each presentation. NFID is committed to resolving all conflicts of interest prior to the educational activity being delivered to participants. In advance of the activity, conflicts of interest may be resolved by either altering control over content or independent peer review and validation of content to verify scientific basis and integrity. Actions that resolve conflicts of interest include: revised faculty assignment; non-conflicted external review of content; peer review of content by planning committee; and best available evidence used in presentation ...
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.. The following faculty/staff members have the following financial relationships with commercial interests:. Kenneth Beckman, MD, and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Carl Zeiss Meditec.. Zaina Al-Mohtaseb, MD, and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Bausch + Lomb, Carl Zeiss Meditec, CorneaGen, and Ocular Therapeutix.. The Evolve staff and planners have no financial relationships with commercial interests.. Nisha Mukherjee, ...
The presence of a conflict of interest is independent of the occurrence of impropriety. Therefore, a conflict of interest can be discovered and voluntarily defused before any corruption occurs. A widely used definition is: "A conflict of interest is a set of circumstances that creates a risk that professional judgement or actions regarding a primary interest will be unduly influenced by a secondary interest." Primary interest refers to the principal goals of the profession or activity, such as the protection of clients, the health of patients, the integrity of research, and the duties of public office. Secondary interest includes not only financial gain but also such motives as the desire for professional advancement and the wish to do favours for family and friends, but conflict of interest rules usually focus on financial relationships because they are relatively more objective, fungible, and quantifiable. The secondary interests are not treated as wrong in themselves, but become objectionable ...
The American College of Medical Genetics and Genomics has implemented a process where everyone who is in a position to influence and/or control the content of a continuing education activity must disclose all relevant financial relationships with any commercial interest within the past 12 months and any conflicts must be resolved prior to the activity. Participants of educational programs must be informed of an organizers and/or a presenters academic and professional affiliations and existence of any relevant financial relationship a presenter has with any proprietary entity producing heath care goods or services consumed by, or used on patients, with the exemption of non-profit or government organization and non-health care related companies. The intent of this disclosure is not to prevent a speaker from making a presentation. This policy allows the participant to be fully knowledgeable in evaluating the information being presented. All disclosures have been reviewed by the Education ...
Disclosure Financial relationships - none with companies or personnel that would have an impact on presentation Financial relationships - married - enough said Other disclosures - wife says I am old and crotchety -probably true I love animals.
The conflict_,schema,_,table, table contains information about conflicting rows in peer-to-peer replication. A conflict table exists for each replicated table in a publication, where the name of the conflict table is appended with the schema and article name. These article-specific conflict tables exist in each publication database.. For peer-to-peer replication, by default, the Distribution Agent fails when it detects a conflict. A conflict error is logged into the error log, but no conflict data is logged into the conflict table; therefore it is not available for viewing. If the Distribution Agent is allowed to continue, a conflict is logged locally on each node where it was detected. For more information, see "Handling Conflicts" in Conflict Detection in Peer-to-Peer Replication. ...
Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.. The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to ...
Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to ...
In the interest of maintaining the independence of its continuing medical education (CME) activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS-USA requires all persons with control of content (ie, faculty, IAS-USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS-USA CME activity.. ...
In the interest of maintaining the independence of its continuing medical education (CME) activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS-USA requires all persons with control of content (ie, faculty, IAS-USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS-USA CME activity.. ...
... Actually, the algae isnt tiring me. Im tired of the people trying to sell it to me. Most blue-green algae is sold in a multi-level marketing scheme through Cell Tech. Sellers see me, a physician, as a potentially lucrative franchise to sell algae for them. So I get two or three sales calls every week (once as many as twenty). Never mind that selling algae to make myself money is a conflict-of-interest and an unethical ploy already encouraged by pharmaceutical companies (The only solution I see for your diagnosis, Mr. Smith, is blue-green algae, which I happen to have right here...). Ive tried the algae and it doesnt do much for me. The cost/benefit ratio is poor. Nevertheless, in the past three years Ive received over 400 phone calls, dozens of tapes in the mail, and had people barge into my office and home, all selling algae. One salesperson has continued to call me for almost three years! So what is blue-green algae and why does it make people so ...
by Alliance for Natural Health These vitamins come from a major drug company. Maybe we should conclude that vitamins made by a drug company reduce cancer and
U.S. Sen. Al Franken (D-Minn.) proposed a bill Nov. 15 that aims to promote devices that treat rare diseases, ease conflict-of-interest regulations for approval committees and lift a profit cap on humanitarian use devices. The legislation would bring devices to market faster, he said.
Ann Elsasser-Root holds a Doctor of Physical Therapy degree from the University of Pittsburgh. She has experience working as a physical therapist in multiple care settings, including skilled nursing, independent living, inpatient rehab, and outpatient orthopedic and neurology. Ann has a strong manual therapy background and has completed additional training in geriatric care, kinesiotaping, vestibular rehabilitation, and McKenzie MDT for the lumbar spine. She is most passionate about treating the older population to improve quality of life and maximize functional independence. As a curriculum designer for Relias, Ann enjoys being able to combine her clinical knowledge with her interest in research and staying up-to-date with changes and advances in the field of rehabilitation. Ann Elsasser-Root, PT DPT has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists ...
Conflict of interest. Avicenna Journals (Advancements in Science) requires all authors to disclose any financial conflict of interest that might be construed to influence the results or interpretation of their manuscript. Authors must declare any such conflict in the cover letter accompanying the manuscript and in the Acknowledgments section of the manuscript itself.. Manuscript Submission. Please write your text in good English (American or British usage is accepted, but not a mixture of these).. Submission to this journal proceeds totally online and you will be guided stepwise through the creation and uploading of your files.. Title Page. The title page should include:. ...
Bonjour Conformance Test Version 1.2.8 Started Tue Nov 20 12:57:22 2012 Completed Wed Nov 21 09:00:08 2012 Link-Local Address Allocation ----------------------------- PASSED: INITIAL PROBING PASSED: PROBING: RATE LIMITING PASSED: PROBING: CONFLICTING SIMULTANEOUS PROBES PASSED: PROBING: PROBE DENIALS PASSED: PROBING COMPLETION WARNING: SUBSEQUENT CONFLICTS: RE-PROBE AFTER FIRST CONFLICT WARNING: SUBSEQUENT CONFLICTS: RE-PROBE AFTER FIRST CONFLICT WARNING: SUBSEQUENT CONFLICTS: RE-PROBE AFTER FIRST CONFLICT WARNING: SUBSEQUENT CONFLICTS: RE-PROBE AFTER FIRST CONFLICT WARNING: SUBSEQUENT CONFLICTS: RE-PROBE AFTER FIRST CONFLICT WARNING: SUBSEQUENT CONFLICTS: RE-PROBE AFTER FIRST CONFLICT WARNING: SUBSEQUENT CONFLICTS: RE-PROBE AFTER FIRST CONFLICT WARNING: SUBSEQUENT CONFLICTS: RE-PROBE AFTER FIRST CONFLICT WARNING: SUBSEQUENT CONFLICTS: RE-PROBE AFTER FIRST CONFLICT PASSED: SUBSEQUENT CONFLICTS PASSED: HOT-PLUG: USE OF PREVIOUS ADDRESS AS FIRST PROBE CANDIDATE PASSED: CABLE CHANGE HANDLING ...
The incoming editor of the journal this week responded to reports about an apparent conflict of interest stemming from his ties to drug companies. Dr. Jeffrey Drazen, who becomes editor in July, said he may have made a mistake last year when he praised a new asthma drug made by a company that had hired him to evaluate studies about the medication. He also said he would divest himself of any financial interests in drug companies before taking over as editor ...
Mr Subash Tandon does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.. Mr Subash Tandon does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.. Mr Subash Tandon does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.. ...
For Health Care Professionals: This same information, written for health care professionals, can be found here.. Disclosure: The authors have no financial conflict of interest relevant to this educational post.. Last updated: June 22nd, 2011. Disclaimer: ClotConnect.org, its contributors, authors, advisors, members and affiliate organizations do not assume any liability for the content of the website, blog and educational materials. Medical information changes rapidly. While information is believed to be correct, no representation is made and no responsibility is assumed for the accuracy of information contained on or available through this web site and blog. Information is subject to change without notice. ...
What Sinclair Lewis admiringly described 80 years ago as "the cold, clear light" of medical science - a single-minded impartial commitment to truth and human welfare transcending all external influence - is becoming hard to find. Instead, we often see only a refracted spectrum of partisan interests that can be impossible to reassemble into truth.. Is the nice pen I accept from a drug company an implicit promise that I will prescribe the drug whose name is etched on its barrel, or is it just a pen? Does the grant money a researcher receives from a pharmaceutical company indicate that the research will be subtly prejudiced, or is it just money? And even when financial issues are not involved, what about all the other less tangible factors that may sway scientific judgments, from the philosophical convictions of interest groups to individual researchers determination to enhance their own reputations?. These questions have escalated in our time, experts say, because our society increasingly forces ...
Northern Trust is a leader in trust and estate services and can administer a broad array of trusts to help meet your unique goals for today and tomorrow.
Strengths of non-financial co-ops ... Non-financial Co-op-Employment Growth ... The most interventionist countries and the most committed in supporting the co ... – A free PowerPoint PPT presentation (displayed as a Flash slide show) on PowerShow.com - id: 144979-ZTY1M
Free Online Library: AMGEN SIGNS WITH SWEDISH DRUG COMPANY.(Business, Statistical Data Included) by Daily News (Los Angeles, CA); News, opinion and commentary General interest Pharmaceutical industry
SAN DIEGO - A drug company will begin selling a low-cost version of Daraprim, a life-saving drug at the centre of a firestorm over the practices of some pharmaceutical companies after it was acquired...
ACCF committee members, faculty, staff and other individuals who are in a position to control the content of this activity are required to disclose all relevant financial relationships he/she and/or his/her spouse or domestic partner has, occurring within the past twelve months, with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. All relevant potential conflicts of interest that are identified are thoroughly vetted through a process that includes course directors and appropriate peer review by education committee chairs/members, for fair balance, scientific objectivity and validity, patient care and safety recommendations. Refer to the links below for committee member disclosures and course faculty disclosures. Please note ACCF staff involved with this course have nothing to disclose. ...
Dear Parliamentary and Health Service Ombudsman,. Can you please provide me with a copy of your policy or documented procedures, which ensure there is no conflict of interest when an internal professional advisor to the PHSO offers health advice re: a complaint about an NHS hospital?. [Extraneous Material removed]. Yours faithfully ...
Trauma: An Evidence Based Perspective was held on August 13th. Over 70 NCPIC members and guests attended this meeting. Here are presentations from Flo Stein and
Integrity Continuing Education and Global Education Group require instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education and Global Education Group for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Integrity Continuing Education and Global Education Group are committed to providing learners with high-quality CME/CE activities and related materials that promote improvement or quality in healthcare and not a specific proprietary business interest or a commercial interest.. The faculty/planners reported their financial relationships or relationships to products or devices they or their spouse/life partner have with ...
So far were not seeing companies or governments say who should PAY for all the coronavirus costs-medical care plus lost sales, lost compensation and lost productivity. On the MedPage Today online newsletter I enjoy, readers and political leaders often call for drug companies to pay for all kinds of things.. We can see one PR peril of drug companies when we read that candidate Yang says drug companies "profited to the tune of tens of billions of dollars" from opioids. He says "we will take back those profits" although billions and billions in opioid sales are for use in hospitals and lawful prescriptions to avoid pain and even agony by millions of patients. Public policy ideas that could be even more costly come from Sen. Klobuchar. She says: "We will get [from drug companies] $40 billion from a coming settlement," and "we can put a 2-cents-per-milligram tax on opioids that brings in another $40 billion.". The PR challenge is for drug and other companies to make clear that there is no free ...
(All posts may contain affiliate links and/or sponsored content. Please see my disclosure policy) If you have a little one on formula or know of someone who
Ten of the worlds biggest drug companies -- normally the most competitive of rivals -- are joining with U.S. health experts in an unusual new effort to develop treatments for major diseases. Th...